mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.007 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.008 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.009 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |